DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Molecular Imaging Homepage

James Allison, Padmanee Sharma and Ramy Ibrahim ImaginAb appoints new members to scientific advisory board

Alliance completes deal for Piramal Imaging Expanding market presence in molecular imaging

Siemens announces first global installation of Biograph Vision PET/CT System yields better temporal resolution and sensitivity than previously reported

New PET tracer could help find cure for Alzheimer's Researchers from Yale show they can measure synaptic density: SNMMI

Spectrum Dynamics launches 12 detector SPECT system The VERITON SPECT system debuted at SNMMI

Cardinal Health showcases first integrated cloud solution for nuclear medicine at SNMMI Nuctrac replaces phone and fax orders

GE launched Syntermed's Emory Cardiac Toolbox at SNMMI Affordable option for users with older SPECT systems

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

SNMMI Exhibitor's Guide A few of the companies you'll want to visit with on the show floor

Q&A with Dr. Satoshi Minoshima, incoming President of SNMMI Find out what to expect at the big event and over the next year

ANSTO has suspended production
of Tc-99m generators following a
mechanical fault in its transfer

Generator production for Tc-99m in Australia suspended following mechanical fault

by John R. Fischer , Staff Reporter
The Australian Nuclear Science and Technology Organisation (ANSTO) has suspended production of generators due to a mechanical fault in its transfer conveyor.

The suspension, which took place in late June, is ongoing, with ANSTO working with international partners to curb disruptions in the transport of Molybdenum (Mo-99) to providers and imaging clinics throughout Australia and abroad.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

“Nuclear medicine production is one of the most complex production processes in Australia today,” a spokesperson for ANSTO said in a statement. “Just like with any other production process, there are occasional mechanical faults and if those happen we work closely with our international partners to minimize impact. While there were no safety risks or issues associated with this mechanical fault, nonetheless, it is causing some inconvenience to our customers.”

ANSTO produces around 10,000 doses of Mo-99 weekly for Australian patients and thousands more for international patients. Upon the completion of production, the parent isotope is placed inside a generator where it decays into the radioisotope, Tc-99m while delivered as a bulk Mo-99 export to hospitals nationwide as well as medical practices in New Zealand and Asia.

To offset delays, shipments of bulk Mo-99 have been sent to Lantheus Medical Imaging Inc. (LMI), a U.S. partner of ANSTO, which is storing the isotope inside its own generators and sending them back to providers in Australia.

Distribution took place on Monday, July 2, with generators delivered to 24 metropolitan hospitals, 12 regional and rural facilities and five Global Medical Solutions Australia (GMS) sites nationwide. Total deliveries equated to just more than 39 percent of normal weekly supply.

A second shipment scheduled to arrive Tuesday was held up in the U.S. due to mechanical issues and was expected to arrive the next morning, while a third batch was scheduled to be delivered to providers this week.

Restoration efforts are expected to continue over the next few weeks, a fact that ANSTO apologizes for and acknowledges may potentially disrupt practices at medical facilities.

“Engineers are continuing to work to rectify the mechanical fault that was identified with a piece of equipment called a transfer conveyer on Friday, June 22. This mechanical fault has not affected other nuclear medicine products from ANSTO, and has no impact on the operation of the OPAL nuclear reactor,” an ANSTO spokesperson said, adding that they are pleased that ANSTO “has been able to secure supply of Technetium-99m (Tc-99m) generators from one of our international partners.”

Unforeseen issues in radiopharmaceutical production and supply can have a serious impact on the ability of providers worldwide to diagnose and treat patients in a timely manner. NTP Radioisotopes recently resumed its own production of Mo-99 in March at its Pelindaba facility in South Africa, following a three-month shutdown initiated upon the discovery of a suspected hydrogen leak.

ANSTO did not respond to HCB News for comment.

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.